OverviewChartNewsTraderScreen

Psychemedics Corporation/  US7443752057  /

NASDAQ
08/07/2024  20:45:53 Chg. -0.0300 Volume Bid22:13:36 Ask22:13:36 High Low
2.4000USD -1.23% 2,561
Turnover: 3,951.4400		 0.9720Bid Size: 200 3.1500Ask Size: 1,600 2.4999 2.4000
GlobeNewswire 21/06 Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
GlobeNewswire 14/05 Psychemedics Corporation Reports First Quarter 2024 Financial Results
GlobeNewswire 28/03 Psychemedics Corporation Reports 2023 Financial Results
GlobeNewswire 21/03 Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
GlobeNewswire 02/01 Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
GlobeNewswire 27/11/2023 Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
GlobeNewswire 09/11/2023 Psychemedics Corporation Reports Third Quarter 2023 Financial Results
GlobeNewswire 27/10/2023 Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
GlobeNewswire 21/09/2023 Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
GlobeNewswire 18/08/2023 Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 22/03/2022 Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retireme...
GlobeNewswire 10/12/2021 Psychemedics Corporation Declares Cash Dividend
GlobeNewswire 12/11/2021 Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Qua...
GlobeNewswire 10/08/2021 Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results
GlobeNewswire 10/05/2021 Psychemedics Corporation Reports First Quarter 2021 Financial Results
GlobeNewswire 23/03/2021 Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results
GlobeNewswire 17/03/2021 Robyn C. Davis Joins Psychemedics Board of Directors
GlobeNewswire 26/01/2021 Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller
GlobeNewswire 17/12/2020 Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel
GlobeNewswire 09/11/2020 Psychemedics Announces Third Quarter Results
GlobeNewswire 12/08/2020 Psychemedics Announces Second Quarter Results
GlobeNewswire 13/05/2020 Psychemedics Announces First Quarter Results
GlobeNewswire 05/05/2020 Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and Nicotine
GlobeNewswire 29/04/2020 Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA
GlobeNewswire 28/04/2020 Psychemedics Corporation to Webcast 2020 Annual Meeting of Stockholders